MeiraGTx Holdings plc (MGTX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 8.09 |
| Open | 8.27 |
| Bid | 8.71 x 900 |
| Ask | 9.29 x 800 |
| Day's Range | 8.27 - 8.83 |
| 52 Week Range | 7.73 - 24.90 |
| Volume | |
| Avg. Volume | 155,467 |
| Market Cap | 389.43M |
| Beta (5Y Monthly) | 1.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.97 |
| Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.57 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MGTX
Related Research
- MeiraGTx Holdings plcRGNX: What does Argus have to say about RGNX?REGENXBIO INC has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat4 days agoArgus Research
- Zacks
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -42.86% and 39.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
MeiraGTx Reports First Quarter 2022 Financial and Operational Results
- Phase 3 Lumeos Clinical Trial of Botaretigene Sparoparvovec (AAV-RPGR) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) Actively Dosing Patients- Phase 1 AQUAx Study of AAV-hAQP1 for Radiation-Induced Xerostomia Completed Dosing of Both Unilateral and Bilateral Cohorts in the First Quarter of 2022 LONDON and NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results fo
- Simply Wall St.
Companies Like MeiraGTx Holdings (NASDAQ:MGTX) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
